COVID-19: Impact of pandemic on Switzerland's ophthalmic space

April 2, 2020

By Alex Delaney-Gesing

Article

Roberto Pinelli, MD, CEO and founder of the Switzerland Eye Research Institute, shares how operations at the facility have adapted to the growing coronavirus pandemic spreading across the globe.

See more coronavirus coverage

Recent Videos

WIO 2024: An educator's perspective on shattering glass ceilings in ophthalmology

Hannah Chiu, MD, FRCSC, highlights some of the early benefits of an AI-operated telephone call system for postoperative patient care at WIO 2024

Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally

ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD

TENAYA, LUCERNE year 2 data reveals promising results for faricimab

How to diagnose geographic atrophy earlier

World Sight Day 2022: Eye care professionals share what global vision means to them

Samsara Vision update: Concerto trial recruiting patients with late-stage AMD

Understanding fluid dynamics in wet macular degeneration

YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.